{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:12:31Z","timestamp":1790770351930,"version":"4.1.0"},"reference-count":64,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health (NIH)","award":["R01AI149795"],"award-info":[{"award-number":["R01AI149795"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>In addition to the rabies virus (RABV), 16 more lyssavirus species have been identified worldwide, causing a disease similar to RABV. Non-rabies-related human deaths have been described, but the number of cases is unknown, and the potential of such lyssaviruses causing human disease is unpredictable. The current rabies vaccine does not protect against divergent lyssaviruses such as Mokola virus (MOKV) or Lagos bat virus (LBV). Thus, a more broad pan-lyssavirus vaccine is needed. Here, we evaluate a novel lyssavirus vaccine with an attenuated RABV vector harboring a chimeric RABV glycoprotein (G) in which the antigenic site I of MOKV replaces the authentic site of rabies virus (RABVG-cAS1). The recombinant vaccine was utilized to immunize mice and analyze the immune response compared to homologous vaccines. Our findings indicate that the vaccine RABVG-cAS1 was immunogenic and induced high antibody titers against both RABVG and MOKVG. Challenge studies with different lyssaviruses showed that replacing a single antigenic site of RABV G with the corresponding site of MOKV G provides a significant improvement over the homologous RABV vaccine and protects against RABV, Irkut virus (IRKV), and MOKV. This strategy of epitope chimerization paves the way towards a pan-lyssavirus vaccine to safely combat the diseases caused by these viruses.<\/jats:p>","DOI":"10.3390\/v16071107","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:22:05Z","timestamp":1720624925000},"page":"1107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Toward the Development of a Pan-Lyssavirus Vaccine"],"prefix":"10.3390","volume":"16","author":[{"given":"Sabrine","family":"Ben Hamed","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-1576","authenticated-orcid":false,"given":"Jacob F.","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Chandwani","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-7700","authenticated-orcid":false,"given":"Drishya","family":"Kurup","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-9660","authenticated-orcid":false,"given":"Nir","family":"Paran","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-9405","authenticated-orcid":false,"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"ref_1","unstructured":"(2024, February 24). Genus: Lyssavirus|ICTV. Available online: https:\/\/ictv.global\/report\/chapter\/rhabdoviridae\/rhabdoviridae\/lyssavirus."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The Spread and Evolution of Rabies Virus: Conquering New Frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Calvelage, S., Tammiranta, N., Nokireki, T., Gadd, T., Eggerbauer, E., Zaeck, L.M., Potratz, M., Wylezich, C., H\u00f6per, D., and M\u00fcller, T. (2021). Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV). Viruses, 13.","DOI":"10.3390\/v13010069"},{"key":"ref_4","unstructured":"(2024, February 24). Rabies. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rabies."},{"key":"ref_5","unstructured":"(2024, February 24). Animals and Rabies|Rabies|CDC, Available online: https:\/\/www.cdc.gov\/rabies\/animals\/index.html."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.5694\/j.1326-5377.2000.tb124126.x","article-title":"Australian Bat Lyssavirus Infection: A Second Human Case, with a Long Incubation Period","volume":"172","author":"Hanna","year":"2000","journal-title":"Med. J. Aust."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3390\/v6020909","article-title":"Recent Observations on Australian Bat Lyssavirus Tropism and Viral Entry","volume":"6","author":"Weir","year":"2014","journal-title":"Viruses"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3201\/eid1212.060764","article-title":"Fatal Human Infection with Rabies-Related Duvenhage Virus, South Africa","volume":"12","author":"Paweska","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.36233\/0507-4088-156","article-title":"Lethal cases of lyssavirus encephalitis in humans after contact with bats in the Russian Far East in 2019\u20132021","volume":"68","author":"Poleshchuk","year":"2023","journal-title":"Vopr. Virusol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/ciab443","article-title":"First Case of Lethal Encephalitis in Western Europe Due to European Bat Lyssavirus Type 1","volume":"74","author":"Regnault","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3201\/eid1203.051306","article-title":"Lagos Bat Virus, South Africa","volume":"12","author":"Markotter","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Coertse, J., Markotter, W., le Roux, K., Stewart, D., Sabeta, C.T., and Nel, L.H. (2017). New Isolations of the Rabies-Related Mokola Virus from South Africa. BMC Vet. Res., 13.","DOI":"10.1186\/s12917-017-0948-0"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1008120511752","article-title":"New Cases of Mokola Virus Infection in South Africa: A Genotypic Comparison of Southern African Virus Isolates","volume":"20","author":"Nel","year":"2000","journal-title":"Virus Genes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QCO.0000000000000420","article-title":"Rabies: Changing Prophylaxis and New Insights in Pathophysiology","volume":"31","author":"Ugolini","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmaid.2011.12.005","article-title":"Current Rabies Vaccines and Prophylaxis Schedules: Preventing Rabies before and after Exposure","volume":"10","author":"Warrell","year":"2012","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"A85","DOI":"10.1016\/j.vaccine.2018.10.014","article-title":"The WHO Position on Rabies Immunization\u20142018 Updates","volume":"37","author":"Nolan","year":"2019","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","article-title":"Structural Analysis of Rabies Virus Glycoprotein Reveals pH-Dependent Conformational Changes and Interactions with a Neutralizing Antibody","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eabp9151","DOI":"10.1126\/sciadv.abp9151","article-title":"Structure of the Rabies Virus Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody","volume":"8","author":"Callaway","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.imj.2022.09.003","article-title":"Research Progress on Neutralizing Epitopes and Antibodies for the Rabies Virus","volume":"1","author":"Shi","year":"2022","journal-title":"Infect. Med."},{"key":"ref_21","unstructured":"(2024, March 27). Novel Rabies Virus-Neutralizing Epitope Recognized by Human Monoclonal Antibody: Fine Mapping and Escape Mutant Analysis. Available online: https:\/\/journals.asm.org\/doi\/epdf\/10.1128\/jvi.79.8.4672-4678.2005?src=getftr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41467-020-14398-7","article-title":"Structure of the Prefusion-Locking Broadly Neutralizing Antibody RVC20 Bound to the Rabies Virus Glycoprotein","volume":"11","author":"Hellert","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4161\/21645515.2014.972741","article-title":"Cross-Neutralization of Antibodies Induced by Vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against Different Lyssavirus Species","volume":"10","author":"Malerczyk","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity","volume":"75","author":"Badrane","year":"2001","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1099\/jgv.0.001068","article-title":"Isolation, Antigenicity and Immunogenicity of Lleida Bat Lyssavirus","volume":"99","author":"Banyard","year":"2018","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Viljoen, N., Weyer, J., Coertse, J., and Markotter, W. (2023). Evaluation of Taxonomic Characteristics of Matlo and Phala Bat Rabies-Related Lyssaviruses Identified in South Africa. Viruses, 15.","DOI":"10.3390\/v15102047"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Belot, L., Ouldali, M., Roche, S., Legrand, P., Gaudin, Y., and Albertini, A.A. (2020). Crystal Structure of Mokola Virus Glycoprotein in Its Post-Fusion Conformation. PLoS Pathog., 16.","DOI":"10.2210\/pdb6tmr\/pdb"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107920","DOI":"10.1016\/j.celrep.2020.107920","article-title":"Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups","volume":"32","author":"Fisher","year":"2020","journal-title":"Cell Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious Rabies Viruses from Cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41541-020-00248-6","article-title":"Rabies Virus-Based COVID-19 Vaccine CORAVAXTM Induces High Levels of Neutralizing Antibodies against SARS-CoV-2","volume":"5","author":"Kurup","year":"2020","journal-title":"NPJ Vaccines"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rios, S., Bhattachan, B., Vavilikolanu, K., Kitsou, C., Pal, U., and Schnell, M.J. (2024). The Development of a Rabies Virus-Vectored Vaccine against Borrelia Burgdorferi, Targeting BBI39. Vaccines, 12.","DOI":"10.3390\/vaccines12010078"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-023-00663-5","article-title":"GP38 as a Vaccine Target for Crimean-Congo Hemorrhagic Fever Virus","volume":"8","author":"Scher","year":"2023","journal-title":"NPJ Vaccines"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-023-00615-z","article-title":"Effects of Adjuvants in a Rabies-Vectored Ebola Virus Vaccine on Protection from Surrogate Challenge","volume":"8","author":"Yankowski","year":"2023","journal-title":"NPJ Vaccines"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10605","DOI":"10.1128\/JVI.00558-11","article-title":"Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses","volume":"85","author":"Blaney","year":"2011","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"(2010). Rabies Vaccines: WHO Position Paper\u2014Recommendations. Vaccine, 28, 7140\u20137142.","DOI":"10.1016\/j.vaccine.2010.08.082"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/prot.25823","article-title":"Critical Assessment of Methods of Protein Structure Prediction (CASP)-Round XIII","volume":"87","author":"Kryshtafovych","year":"2019","journal-title":"Proteins"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kgaladi, J., Faber, M., Dietzschold, B., Nel, L.H., and Markotter, W. (2017). Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2030037"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.vaccine.2016.08.013","article-title":"Vaccine-Induced Rabies Case in a Cow (Bos Taurus): Molecular Characterisation of Vaccine Strain in Brain Tissue","volume":"34","author":"Vuta","year":"2016","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"(2024, April 23). Viruses|Free Full-Text|Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses. Available online: https:\/\/www.mdpi.com\/1999-4915\/10\/3\/130.","DOI":"10.3390\/v10030130"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/zph.12352","article-title":"Barriers to Innovation in Human Rabies Prophylaxis and Treatment: A Causal Analysis of Insights from Key Opinion Leaders and Literature","volume":"64","author":"Neevel","year":"2017","journal-title":"Zoonoses Public Health"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1135710","article-title":"Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G","volume":"315","author":"Roche","year":"2007","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12250-016-3734-4","article-title":"Immunogenicity of Multi-Epitope-Based Vaccine Candidates Administered with the Adjuvant Gp96 against Rabies","volume":"31","author":"Niu","year":"2016","journal-title":"Virol. Sin."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6026\/97320630019167","article-title":"Design and Construction of Multi Epitope- Peptide Vaccine Candidate for Rabies Virus","volume":"19","author":"Hashim","year":"2023","journal-title":"Bioinformation"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ding, Y., Gao, Y., Chen, R., Zhang, Z., Li, Q., Jia, T., Zhang, T., Xu, R., Shi, W., and Chen, L. (2024). Development of a Novel Multi-Epitope Oral DNA Vaccine for Rabies Based on a Food-Borne Microbial Vector. Int. J. Biol. Macromol., 255.","DOI":"10.1016\/j.ijbiomac.2023.128085"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1016\/j.vaccine.2009.06.095","article-title":"Antibodies Induced by Vaccination with Purified Chick Embryo Cell Culture Vaccine (PCECV) Cross-Neutralize Non-Classical Bat Lyssavirus Strains","volume":"27","author":"Malerczyk","year":"2009","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fooks, A.R., Shipley, R., Markotter, W., Tordo, N., Freuling, C.M., M\u00fcller, T., McElhinney, L.M., Banyard, A.C., and Rupprecht, C.E. (2021). Renewed Public Health Threat from Emerging Lyssaviruses. Viruses, 13.","DOI":"10.3390\/v13091769"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies Human Diploid Cell Vaccine Elicits Cross-Neutralising and Cross-Protecting Immune Responses against European and Australian Bat Lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1128\/JCM.01565-13","article-title":"Evaluation of Rabies Biologics against Irkut Virus Isolated in China","volume":"51","author":"Liu","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, S., Zhao, J., Zhang, F., and Hu, R. (2013). Isolation of Irkut Virus from a Murina Leucogaster Bat in China. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002097"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of Rabies Biologics against New Lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Hayman, D.T.S., Fooks, A.R., Marston, D.A., and Garcia-R, J.C. (2016). The Global Phylogeography of Lyssaviruses\u2014Challenging the \u201cOut of Africa\u201d Hypothesis. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005266"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0035-9203(90)90103-L","article-title":"Serological Evidence of Infection of Dogs and Man in Nigeria by Lyssaviruses (Family Rhabdoviridae)","volume":"84","author":"Ogunkoya","year":"1990","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1006\/viro.1994.1576","article-title":"Propagation of Pseudorabies Virus in the Nervous System of the Mouse after Intranasal Inoculation","volume":"204","author":"Babic","year":"1994","journal-title":"Virology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0042-6822(91)90145-2","article-title":"Spread of the CVS Strain of Rabies Virus and of the Avirulent Mutant AvO1 along the Olfactory Pathways of the Mouse after Intranasal Inoculation","volume":"183","author":"Lafay","year":"1991","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nri1105","article-title":"Immune Responses to RNA-Virus Infections of the CNS","volume":"3","author":"Griffin","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_57","unstructured":"(2024, April 01). Recovery of a Patient from Clinical Rabies\u2014California, Available online: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6104a1.htm."},{"key":"ref_58","first-page":"21","article-title":"Recovery from Rabies, a Universally Fatal Disease","volume":"3","author":"Manoj","year":"2016","journal-title":"Mil. Med. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gold, S., Donnelly, C.A., Nouvellet, P., and Woodroffe, R. (2020). Rabies Virus-Neutralising Antibodies in Healthy, Unvaccinated Individuals: What Do They Mean for Rabies Epidemiology?. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0007933"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01964-06","article-title":"Failure to Open the Blood-Brain Barrier and Deliver Immune Effectors to Central Nervous System Tissues Leads to the Lethal Outcome of Silver-Haired Bat Rabies Virus Infection","volume":"81","author":"Roy","year":"2007","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-387040-7.00004-4","article-title":"Rabies Virus Clearance from the Central Nervous System","volume":"79","author":"Hooper","year":"2011","journal-title":"Adv. Virus Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e16394","DOI":"10.15252\/emmm.202216394","article-title":"mAb Therapy Controls CNS-resident Lyssavirus Infection via a CD4 T Cell-dependent Mechanism","volume":"15","author":"Mastraccio","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1073\/pnas.0807656105","article-title":"Blood-Brain Barrier Changes and Cell Invasion Differ between Therapeutic Immune Clearance of Neurotrophic Virus and CNS Autoimmunity","volume":"105","author":"Fabis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hooper, D.C., Phares, T.W., Fabis, M.J., and Roy, A. (2009). The Production of Antibody by Invading B Cells Is Required for the Clearance of Rabies Virus from the Central Nervous System. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000535"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:12:58Z","timestamp":1760109178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/7\/1107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["v16071107"],"URL":"https:\/\/doi.org\/10.3390\/v16071107","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}